These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36480278)

  • 21. A 'Real Life' Service Evaluation Model for Multidisciplinary Thyroid Eye Services.
    Farag S; Feeney C; Lee V; Nagendran S; Jain R; Aziz A; Akishar R; Bravis V; Meeran K
    Front Endocrinol (Lausanne); 2021; 12():669871. PubMed ID: 34025584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An update on thyroid-associated ophthalmopathy in children and adolescents.
    Szczapa-Jagustyn J; Gotz-Więckowska A; Kocięcki J
    J Pediatr Endocrinol Metab; 2016 Oct; 29(10):1115-1122. PubMed ID: 27682712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of thyroid orbitopathy.
    Rose JG; Burkat CN; Boxrud CA
    Otolaryngol Clin North Am; 2005 Oct; 38(5):1043-74. PubMed ID: 16214573
    [No Abstract]   [Full Text] [Related]  

  • 24. Compressive Optic Neuropathy in Thyroid Eye Disease.
    Thyparampil P; Yen MT
    Int Ophthalmol Clin; 2016; 56(1):51-67. PubMed ID: 26626932
    [No Abstract]   [Full Text] [Related]  

  • 25. Fourth International Thyroid Eye Disease Symposium: Introduction.
    Uddin JM
    Ophthalmic Plast Reconstr Surg; 2018; 34(4S Suppl 1):S1-S2. PubMed ID: 29985834
    [No Abstract]   [Full Text] [Related]  

  • 26. [Graves' ophthalmopathy].
    Eckstein A; Dekowski D; Führer-Sakel D; Berchner-Pfannschmidt U; Esser J
    Ophthalmologe; 2016 Apr; 113(4):349-64; quiz 465-6. PubMed ID: 27059986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Commentary: Multidisciplinary team approach to tackle thyroid eye disease.
    Mahesh L
    Indian J Ophthalmol; 2020 Aug; 68(8):1615-1616. PubMed ID: 32709790
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of criteria for evaluating clinical response in thyroid eye disease using a modified Delphi technique.
    Douglas RS; Tsirbas A; Gordon M; Lee D; Khadavi N; Garneau HC; Goldberg RA; Cahill K; Dolman PJ; Elner V; Feldon S; Lucarelli M; Uddin J; Kazim M; Smith TJ; Khanna D;
    Arch Ophthalmol; 2009 Sep; 127(9):1155-60. PubMed ID: 19752424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Graves' ophthalmopathy.
    González-García A; Sales-Sanz M
    Med Clin (Barc); 2021 Feb; 156(4):180-186. PubMed ID: 33069387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Strabismus associated with thyroid eye disease.
    Schotthoefer EO; Wallace DK
    Curr Opin Ophthalmol; 2007 Sep; 18(5):361-5. PubMed ID: 17700227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical practice. Graves' ophthalmopathy.
    Bartalena L; Tanda ML
    N Engl J Med; 2009 Mar; 360(10):994-1001. PubMed ID: 19264688
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of Graves' disease in patients with thyroid eye disease].
    Sviridenko NY; Sheremeta MS; Belovalova IM; Melnichenko GA
    Vestn Oftalmol; 2021; 137(6):128-135. PubMed ID: 34965078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid Eye Disease.
    Szelog J; Swanson H; Sniegowski MC; Lyon DB
    Mo Med; 2022; 119(4):343-350. PubMed ID: 36118816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Graves' ophthalmopathy from the internist's perspective].
    Laubner K; Weber WA; Seufert J
    Ophthalmologe; 2011 May; 108(5):410-6. PubMed ID: 21590351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Graves' ophthalmopathy].
    Hiromatsu Y
    Nihon Rinsho; 2006 May; Suppl 1():307-10. PubMed ID: 16776151
    [No Abstract]   [Full Text] [Related]  

  • 36. Thyroid eye disease for the primary care physician.
    Phelps PO; Williams K
    Dis Mon; 2014 Jun; 60(6):292-8. PubMed ID: 24906675
    [No Abstract]   [Full Text] [Related]  

  • 37. Management of Graves ophthalmopathy - 2022 update.
    Jiskra J
    Cas Lek Cesk; 2022; 161(5):198-206. PubMed ID: 36443100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid-Associated Orbitopathy: Management and Treatment.
    Hennein L; Robbins SL
    J Binocul Vis Ocul Motil; 2022; 72(1):32-46. PubMed ID: 34874796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L; Muzi G; Cofini M; Leonardi A; Lanciotti L; Esposito S
    Int J Environ Res Public Health; 2019 Jan; 16(1):. PubMed ID: 30626069
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymmetric Graves' Orbitopathy.
    Panagiotou G; Perros P
    Front Endocrinol (Lausanne); 2020; 11():611845. PubMed ID: 33391188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.